Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Increased Framingham 10-year CVD risk in Chinese patients with schizophrenia.

Tay YH, Nurjono M, Lee J.

Schizophr Res. 2013 Jun;147(1):187-92. doi: 10.1016/j.schres.2013.03.023. Epub 2013 Apr 13.

PMID:
23590873
2.

The relationship of metabolic syndrome and constitutional medicine for the prediction of cardiovascular disease.

Cho NH, Kim JY, Kim SS, Shin C.

Diabetes Metab Syndr. 2013 Oct-Dec;7(4):226-32. doi: 10.1016/j.dsx.2013.08.003. Epub 2013 Sep 2.

PMID:
24290090
3.

The metabolic syndrome increased risk of cardiovascular events in Chinese--a community based study.

Wang C, Hou X, Bao Y, Pan J, Zuo Y, Zhong W, Jia W, Xiang K.

Int J Cardiol. 2010 Mar 4;139(2):159-65. doi: 10.1016/j.ijcard.2008.10.012. Epub 2008 Nov 28.

PMID:
19046783
4.

Obese schizophrenia spectrum patients have significantly higher 10-year general cardiovascular risk and vascular ages than obese individuals without severe mental illness.

Ratliff JC, Palmese LB, Reutenauer EL, Srihari VH, Tek C.

Psychosomatics. 2013 Jan-Feb;54(1):67-73. doi: 10.1016/j.psym.2012.03.001. Epub 2012 Jun 2.

5.

Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine: a retrospective cohort study.

Kelly DL, McMahon RP, Liu F, Love RC, Wehring HJ, Shim JC, Warren KR, Conley RR.

J Clin Psychiatry. 2010 Mar;71(3):304-11. doi: 10.4088/JCP.08m04718yel. Epub 2010 Jan 12.

6.

Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis.

Yeboah J, Folsom AR, Burke GL, Johnson C, Polak JF, Post W, Lima JA, Crouse JR, Herrington DM.

Circulation. 2009 Aug 11;120(6):502-9. doi: 10.1161/CIRCULATIONAHA.109.864801. Epub 2009 Jul 27.

7.

Cardiovascular risk prediction models for people with severe mental illness: results from the prediction and management of cardiovascular risk in people with severe mental illnesses (PRIMROSE) research program.

Osborn DP, Hardoon S, Omar RZ, Holt RI, King M, Larsen J, Marston L, Morris RW, Nazareth I, Walters K, Petersen I.

JAMA Psychiatry. 2015 Feb;72(2):143-51. doi: 10.1001/jamapsychiatry.2014.2133.

8.

Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in asian diabetic patients? Analysis from the Japan Diabetes Complications Study.

Sone H, Mizuno S, Fujii H, Yoshimura Y, Yamasaki Y, Ishibashi S, Katayama S, Saito Y, Ito H, Ohashi Y, Akanuma Y, Yamada N; Japan Diabetes Complications Study.

Diabetes Care. 2005 Jun;28(6):1463-71.

PMID:
15920069
9.

The relationship between serum brain-derived neurotrophic factor (BDNF) and cardiometabolic indices in schizophrenia.

Nurjono M, Tay YH, Lee J.

Schizophr Res. 2014 Aug;157(1-3):244-8. doi: 10.1016/j.schres.2014.05.024. Epub 2014 Jun 14.

PMID:
24934904
10.

Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes.

Clair C, Rigotti NA, Porneala B, Fox CS, D'Agostino RB, Pencina MJ, Meigs JB.

JAMA. 2013 Mar 13;309(10):1014-21. doi: 10.1001/jama.2013.1644.

11.

[Relationship between metabolic diseases and all-cause and cardiovascular death in an elderly male population during a 15-year follow-up].

Sun B, Shao Y, Li J, Tian H, Li C.

Zhonghua Yi Xue Za Zhi. 2014 Apr 1;94(12):913-8. Chinese.

PMID:
24854911
12.

Risk of smoking and metabolic syndrome for incidence of cardiovascular disease--comparison of relative contribution in urban Japanese population: the Suita study.

Higashiyama A, Okamura T, Ono Y, Watanabe M, Kokubo Y, Okayama A.

Circ J. 2009 Dec;73(12):2258-63. Epub 2009 Oct 17.

13.

Cardiovascular risk prediction in a population with the metabolic syndrome: Framingham vs. UKPDS algorithms.

Zomer E, Liew D, Owen A, Magliano DJ, Ademi Z, Reid CM.

Eur J Prev Cardiol. 2014 Mar;21(3):384-90. doi: 10.1177/2047487312449307. Epub 2012 May 15.

PMID:
22588087
14.

Metabolic disorders increase the risk to incident cardiovascular disease in middle-aged and elderly Chinese.

Zhang ML, Hou XH, Zhu YX, Lu JX, Peng LP, Gu HL, Jia WP.

Biomed Environ Sci. 2012 Feb;25(1):38-45. doi: 10.3967/0895-3988.2012.01.006.

15.

A population-based cohort study to elucidate temporal relationship between schizophrenia and metabolic syndrome (KCIS no. PSY3).

Chang JC, Yen AM, Lee CS, Chen SL, Chiu SY, Fann JC, Chen HH.

Schizophr Res. 2013 Dec;151(1-3):158-64. doi: 10.1016/j.schres.2013.09.017. Epub 2013 Oct 6.

PMID:
24103573
16.

Prevalence and prognostic impact of subclinical cardiovascular disease in individuals with the metabolic syndrome and diabetes.

Ingelsson E, Sullivan LM, Murabito JM, Fox CS, Benjamin EJ, Polak JF, Meigs JB, Keyes MJ, O'Donnell CJ, Wang TJ, D'Agostino RB Sr, Wolf PA, Vasan RS.

Diabetes. 2007 Jun;56(6):1718-26. Epub 2007 Mar 16.

17.

Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria.

Salazar MR, Carbajal HA, Espeche WG, Aizpurúa M, Leiva Sisnieguez CE, March CE, Balbín E, Stavile RN, Reaven GM.

J Intern Med. 2013 Jun;273(6):595-601. doi: 10.1111/joim.12036. Epub 2013 Feb 18.

18.

Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.

Persson M, Hedblad B, Nelson JJ, Berglund G.

Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1411-6. Epub 2007 Apr 12.

19.

Standard cardiovascular disease risk algorithms underestimate the risk of cardiovascular disease in schizophrenia: evidence from a national primary care database.

McLean G, Martin JL, Martin DJ, Guthrie B, Mercer SW, Smith DJ.

Schizophr Res. 2014 Oct;159(1):176-81. doi: 10.1016/j.schres.2014.07.022. Epub 2014 Aug 13.

PMID:
25128454
20.
Items per page

Supplemental Content

Write to the Help Desk